arrow
D

Diane Gbesemete

University of Southampton
H指数:13
被引数:3,095

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation

BPZE1疫苗接种诱导产生与人类鼻粘膜分泌性IgA反应相关的IL-17+和IL-22+ CD4+ T细胞:对致病性百日咳博德特菌定植的影响

2026-04-180
OAAI
Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study

安全性、定植动力学、传染性和保护性免疫相关性在接种了Bordetella pertussis的英国健康成年人中的研究:一项单中心、开放标签、1期、受控人体感染研究

2026-03-230
OAAI
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis

活 attenuated 鼻内百日咳疫苗 BPZE1 在英国的有效性、免疫原性和安全性:一项采用毒力性 Bordetella pertussis 的受控人体感染模型进行的随机、安慰剂对照、2b 期试验

2025-12-010
OAAI
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

ChAd63/MVA Pfs25-IMX313在第一阶段人体试验中的安全性和免疫原性

2021-07-1426
OAAI
A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage

重组共生细菌在咽部运输过程中引发异源抗原特异性免疫反应

2021-07-077
OA
Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
2018-10-0942
OAAI
Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation
2018-01-1921
OAAI